Humana stock is trading -9.43% below its average target price of $298.95 after dropping -1.7% during today's afternoon session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $250.0 to $353.0 per share.
Humana's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.3%. The stock's short ratio is 2.73. The company's insiders own 0.21% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 96.1%. In conclusion, we believe there is mixed market sentiment regarding Humana.
Institutions Invested in Humana
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 12% | 14,199,096 | $3,844,476,306 |
| 2025-06-30 | Dodge & Cox Inc | 9% | 11,352,920 | $3,073,859,910 |
| 2025-06-30 | Blackrock Inc. | 9% | 10,245,750 | $2,774,088,091 |
| 2025-06-30 | State Street Corporation | 4% | 5,377,390 | $1,455,955,255 |
| 2025-06-30 | Pzena Investment Management LLC | 3% | 4,076,667 | $1,103,777,993 |
| 2025-06-30 | Eagle Capital Management LLC | 3% | 3,949,474 | $1,069,339,852 |
| 2025-06-30 | FMR, LLC | 3% | 3,146,946 | $852,051,379 |
| 2025-06-30 | Geode Capital Management, LLC | 3% | 3,130,829 | $847,687,621 |
| 2025-06-30 | JPMORGAN CHASE & CO | 3% | 3,013,306 | $815,867,680 |
| 2025-06-30 | Sessa Capital IM, L.P. | 2% | 2,123,965 | $575,074,153 |
